Share Prices & Company Research

Stockbroking

Silver Falcon Plc

Current Price 0.00p Bid 0.00p Ask 0.00p Change 0.00%
Last Updated: 19/04/2024 15:01. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Hemogenyx Pharmaceuticals Plc is a biotechnology company developing novel therapies to transform bone marrow and blood stem cell transplantation, announces the readmission of its enlarged issued share capital to the standard listing segment of the Official List and to trading on the main market for listed securities of the London Stock Exchange. The Company is the holding company for Hemogenyx LLC, a US-based biotechnology company developing therapies to transform bone marrow and blood stem cell transplantation. These therapies will replace the need for existing methods of preparation of patients for a transplantation such as chemotherapy and radiation treatments, and will address the problem of finding a matching stem cell donor and reduce the risk of blood stem cell rejection after transplantation.

Financial Highlights Year Ended 31/12/2022

Revenue
£n/am
Operating Profit/Loss
£-4.00m
Dividend yield (%)
n/a
Total dividend for year
n/ap
Dividend cover
n/a
P/E Ratio
n/a
More Financials

Key Personnel

Dr Vladislav Sandler Ph.D.
Chief Executive Officer
Sir Marc Feldmann
Executive Chairman
Mr Peter Redmond
Non-Executive Director
Ms Alexis M. Sandler
Non-Executive Director

Stock Details

EPIC
SILFL
ISIN
GB00BYX3WZ24
Shares in Issue
64.90m
Market cap
£0.00m

Analyst Views (0)

Strong Buy
 
0%
Buy
 
0%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
0.00p
Bid Price
0.00p
Ask Price
0.00p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
0.00p
Previous Close
0.00p
Intraday High
0.00p
Intraday Low
0.00p
52 Week High
0.00p
52 Week Low
0.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

More Charts

Income Statement

Year End Date
31 Dec 2022
31 Dec 2021
 
£ (M)
£ (M)
Continuing Operations
Revenue
n/a
n/a
Operating Profit/Loss
-4.00
-2.70
Net Interest
0.01
-2.58
Pre-Tax Profit
-3.99
-5.11
Profit After Tax from continuing operations
-3.99
-5.11
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
-3.99
-5.11
Attributable to:
Equity Holders of Parent Company
-3.98
-5.10
Minority Interests
-0.01
-0.01
Total Dividend Paid
n/ap
n/ap
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Dec 2022
31 Dec 2021
Basic
-0.50p
-0.70p
Diluted
-0.50p
-0.70p
Adjusted
-0.50p
-0.70p
Dividend per Share
n/ap
n/ap

Assets

Year End Date
31 Dec 2022
31 Dec 2021
 
£ (M)
£ (M)
Non-Current Assets
Property, Plant & Equipment
3.92
0.80
Intangible Assets
0.44
0.44
Investment Properties
n/a
n/a
Investments
n/a
n/a
Other Financial Assets
n/a
n/a
Other Non-Current Assets
0.14
0.14
Current Assets
Inventories
n/a
n/a
Trade & Other Receivables
0.06
0.30
Cash at Bank & In Hand
2.53
6.84
Current Asset Investments
n/a
n/a
Other Current Assets
n/a
n/a
Other Assets
n/a
n/a
Total Assets
7.09
8.52

Liabilities

Year End Date
31 Dec 2022
31 Dec 2021
 
£ (M)
£ (M)
Current Liabilities
Borrowings
0.32
0.01
Other Current Liabilities
0.43
0.34
Total Current Liabilities
0.75
0.35
Non-Current Liabilities
Borrowings
3.10
n/a
Provisions
n/a
n/a
Other Non-Current Liabilities
n/a
n/a
Total Non-Current Liabilities
3.10
n/a
Other Liabilities
n/a
n/a
Total Liabilities
3.85
0.35

Net Assets

Year End Date
31 Dec 2022
31 Dec 2021
 
£ (M)
£ (M)
Net Assets
3.24
8.17

Capital & Reserves

Year End Date
31 Dec 2022
31 Dec 2021
 
£ (M)
£ (M)
Share Capital
9.80
9.80
Share Premium Account
16.81
16.81
Other Reserves
-6.22
-5.28
Retained Earnings
-17.11
-13.13
Shareholders Funds
3.28
8.19
Minority Interests/Other Equity
-0.03
-0.02
Total Equity
3.24
8.17

Dividend History

Dividend Metrics

Year End Date
31 Dec 2022
31 Dec 2021
Dividend growth
n/a%
n/a%
Dividend yield
n/a%
n/a%
Dividend cover
n/a
n/a


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.